O-011Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC)
Merle, P, Rimassa, L, Ryoo, B, Cicin, I, Harris, W, Banu, E, Sarker, D, Tan, B, Van Vlierberghe, H, Sen, S, Love, C, Cheng, A, Meyer, T, Kelley, R, Abou-Alfa, GVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy149.010
Date:
June, 2018
File:
PDF, 77 KB
2018